Cancer treatment and survivorship statistics, 2012

Abstract

Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the population and improvements in survival rates. As a result, it is increasingly important to understand the unique medical and psychosocial needs of survivors and be aware of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship. To highlight the challenges and opportunities to serve these survivors, the American Cancer Society and the National Cancer Institute estimated the prevalence of cancer survivors on January 1, 2012 and January 1, 2022, by cancer site. Data from Surveillance, Epidemiology, and End Results (SEER) registries were used to describe median age and stage at diagnosis and survival; data from the National Cancer Data Base and the SEER-Medicare Database were used to describe patterns of cancer treatment. An estimated 13.7 million Americans with a history of cancer were alive on January 1, 2012, and by January 1, 2022, that number will increase to nearly 18 million. The 3 most prevalent cancers among males are prostate (43%), colorectal (9%), and melanoma of the skin (7%), and those among females are breast (41%), uterine corpus (8%), and colorectal (8%). This article summarizes common cancer treatments, survival rates, and posttreatment concerns and introduces the new National Cancer Survivorship Resource Center, which has engaged more than 100 volunteer survivorship experts nationwide to develop tools for cancer survivors, caregivers, health care professionals, advocates, and policy makers.

Nanoparticulation of BCG-CWS for application to bladder cancer therapy

“…In Europe and the USA, bladder cancer is the fourth most common form of cancer in men. For example, 437,180 men were bladder cancer patients on January 1, 2012 in the USA [17]. NMIBC represents 80% of the incident cases of bladder cancer [18].…”

External Validation of a Clinical Scoring System for Hematuria

“…In 2012, bladder cancer accounted for 7% of new cancer diagnoses and 3% of cancer deaths in American men (Siegel et al, 2012). Approximately 25% of the patients with bladder cancer present with muscle-invasive diseases at diagnosis.…”

Survival of Patients with Prostate Cancer in Yazd, Iran

“…In the United States, prostate cancer was estimated to account for 29% of new cases of cancer, and 9% of cancer-related mortality in adult male population in 2012 . Over the past few decades, incident rates for prostate cancer have increased by epidemic proportions; owing primarily to the enhanced availability of medical surveillance and also advancements in screening strategies (Siegel et al, 2012a;2012b). Hence, in countries such as the US, where the use of screening tests is common, an 80-fold higher incidence rate compared with China has been observed (Jemal et al, 2002).…”